Mean values ± standard error of demographic characteristics, neuropsychological and ARWMC scores of the MCI subgroups. F/m, female/male. Age and education are expressed in years
1. Introduction
We evaluated the changes induced by cerebrovascular damage (CVD and ) and amigdalo-hippocampal atrophy (AHC) on brain rhythmicity as revelaled by scalp electroencephalography (EEG) in a cohort of subjects with mild cognitive impairment (MCI).
All MCI subjects (Mini-Mental State Examination [MMSE] mean score 26.6). All subjects underwent EEG recording and magnetic resonance imaging (MRI). EEGs were recorded at rest. Relative power was separately computed for delta, theta, alpha1, alpha2, and alpha3 frequency bands.
In the spectral bandpower the severity of cerebrovascular damage (CVD) was associated with increased delta power and decreased alpha2 power. No association of vascular damage was observed with alpha3 power. Moreover, the theta/alpha 1 ratio could be a reliable index for the estimation of the individual extent of CV damage. On the other side, the group with moderate hippocampal atrophy showed the highest increase of alpha2 and alpha3 power. Moreover, when the amygdalar and hippocampal volume (AHC) are separately considered, within AHC, the increase of theta/gamma ratio is best associated with amygdalar atrophy whereas alpha3/alpha2 ratio is best associated with hippocampal atrophy.
CVD and AHC are associated with specific EEG markers. So far, these EEG markers could have a prospective value in differential diagnosis between vascular and degenerative MCI. Moreover, EEG markers could be expression of different global network pathological changes, better explaining MCI state.
Mild cognitive impairment (MCI) is a clinical state intermediate between elderly normal cognition and dementia which affects a significant amount of the elderly population, featuring memory complaints and cognitive impairment on neuropsychological testing, but no dementia (Flicker et al., 1991; Petersen et al., 1995, 2001).
The hippocampus is one of the first and most affected brain regions impacted by both Alzheimer’s disease and mild cognitive impairment (MCI; Arnold et al., 1991; Bobinski et al., 1995; Price and Morris, 1999; Schonheit et al., 2004; Bennett et al., 2005, Frisoni et al., 2009). In mild-to-moderate Alzheimer’s disease patients, it has been shown that hippocampal volumes are 27% smaller than in normal elderly controls (Callen et al., 2001; Du et al., 2001), whereas patients with MCI show a volume reduction of 11% (Du et al., 2001). So far, from a neuropathological point of view, the progression of disease from early or very early MCI to later stages seems to follow a linear course. Nevertheless, there is some evidence from functional (Gold et al., 2000; Della Maggiore et al., 2002; Hamalaainen et al., 2006) and biochemical studies (Lavenex and Amaral, 2000) that the process of conversion from non-demented to clinically-evident demented state is not so linear. Recent fMRI studies have suggested increased medial temporal lobe (MTL) activations in MCI subjects vs controls, during the performance of memory tasks (Dickerson et al., 2004, 2005). Nonetheless, fMRI findings in MCI are discrepant, as MTL hypoactivation similar to that seen in AD patients (Pariente et al., 2005) has also been reported (Machulda et al., 2003). Recent postmortem data from subjects – who had been prospectively followed and clinically characterized up to immediately before their death – indicate that hippocampal choline acetyltransferase levels are reduced in Alzheimer’s dementia, but in fact they are upregulated in MCI (Lavenex and Amaral, 2000), presumably because of reactive upregulations of the enzyme activity in the unaffected hippocampal cholinergic axons. Previous EEG studies (Jelic et al. 2000, 1996; Ferreri et al., 2003,Pijnenburg et al., 2004; Jiang et al., 2005, 2006, Zheng et al., 2007) have shown a decrease – ranging from 8 to 10.5 Hz (low alpha) – of the alpha frequency power band in MCI subjects, when compared to normal elderly controls (Zappoli et al., 1995; Huang et al., 2000; Jelic et al., 2000; Koenig et al., 2005; Babiloni et al., 2006). However, a recent study has shown an increase – ranging from 10.5 to 13 Hz (high alpha) – of the alpha frequency power band, on the occipital region in MCI subjects, when compared to normal elderly and AD patients (Babiloni et al., 2006). These somewhat contradictory findings may be explained by the possibility that MCI subjects have different patterns of plastic organization during the disease, and that the activation (or hypoactivation) of different cerebral areas is based on various degrees of hippocampal atrophy. If this hypothesis is true, then EEG changes of rhythmicity have to occur non-proportionally to the hippocampal atrophy, as previously demonstrated in a study of auditory evoked potentials (Golob et al, 2007).
In a recent study (Moretti et al., 2007a), the results confirm the hypothesis that the relationship between hippocampal volume and EEG rhythmicity is not proportional to the hippocampal atrophy, as revealed by the analyses of both the relative band powers and the individual alpha markers. Such a pattern seems to emerge because, rather than a classification based on clinical parameters, discrete hippocampal volume differences (about 1 cm3) are analyzed. Indeed, the group with moderate hippocampal atrophy showed the highest increase in the theta power on frontal regions, and of the alpha2 and alpha3 powers on frontal and temporo-parietal areas.
Recently, two specific EEG markers, theta/gamma and alpha3/alpha2 frequency ratio have been reliable associated to the atrophy of amygdalo-hippocampal complex (Moretti et al. 2008), as well as with memory deficits, that are a major risk for the development of AD in MCI subjects (Moretti et al., 2009). Based on the tertiles values of decreasing AHC volume, three groups of AHC growing atrophy were obtained. AHC atrophy is associated with memory deficits as well as with increase of theta/gamma and alpha3/alpha2 ratio. Moreover, when the amygdalar and hippocampal volume are separately considered, within AHC, the increase of theta/gamma ratio is best associated with amygdalar atrophy whereas alpha3/alpha2 ratio is best associated with hippocampal atrophy.
The role of cerebrovascular (CV) disease and ischemic brain damage in cognitive decline remains controversial. Although not all patients with mild cognitive impairment due to CV damage develop a clinically defined dementia, all such patients are at risk and could develop dementia in the 5 years following the detection of cognitive decline. Cognitive impairment due to subcortical CV damages is thought to be caused by focal or multifocal lesions involving strategic brain areas. These lesions in basal ganglia, thalamus or connecting white matter induce interruption of thalamocortical and striatocortical pathways. As a consequence, deafferentation of frontal and limbic cortical structures is produced. The pattern of cognitive impairment is consistent with models of impaired cortical and subcortical neuronal pathways (Kramer et al., 2002). Even when CV pathology appears to be the main underlying process, the effects of the damaged brain parenchyma are variable and, therefore, the clinical, radiological and pathological appearances may be heterogeneous. A neurophysiological approach could be helpful in differentiating structural from functional CV damage (Moretti et al., 2007b). The quantitative analysis of electroencephalographic (EEG) rhythms in resting subjects is a low-cost but still powerful approach to the study of elderly subjects in normal aging, MCI and dementia.
2. Materials and methods
2.1. Subjects
2.1.1. Cerebrovascular impairment
For the present study, 99 subjects with MCI were recruited. All experimental protocols had been approved by the local Ethics Committee. Informed consent was obtained from all participants or their caregivers, according to the Code of Ethics of the World Medical Association (Declaration of Helsinki). Table 1 shows the main features of this group.
GROUP 1 | GROUP 2 | GROUP 3 | GROUP 4 | |
SUBJECTS (F/M) | 27 (18/9) | 41 (31/10) | 19 (10/9) | 12 (9/3) |
AGE | 70.1 (±1.7) | 69.9 (±1.1) | 69.7 (±1.9) | 70.5 (±2.4) |
EDUCATION | 7.1 (±0.7) | 7 (±0.6) | 7 (±0.9) | 10 (±1.6) |
MMSE | 26.7 (±0.4) | 26.5 (±0.4) | 27 (±0.4) | 26.1 (±0.7) |
ARWMC scale | 0 | 1-5 | 6-10 | 11-15 |
2.2. Degenerative impairment
2.1.1. Subjects
For the present study, 79 subjects with MCI were recruited from the memory Clinic of the Scientific Institute for Research and Care (IRCCS) of Alzheimer’s and psychiatric diseases ‘Fatebenefratelli’ in Brescia, Italy. All experimental protocols had been approved by the local Ethics Committee. Informed consent was obtained from all participants or their caregivers, according to the Code of Ethics of the World Medical Association (Declaration of Helsinki). Table 2 shows the main characteristic of the group.
GROUP 1 | GROUP 2 | GROUP 3 | GROUP 4 | |
t/a1 | 0,7 (±0.05) | 0,77 (±0.05) | 1,17 (±0.05) | 1,39 (±0.14) 0,47 (±0.04) 0,79 (±0.07) |
a1/a2 | 0,46 (±0.03) | 0,5 (±0.03) | 0,53 (±0.05) | |
a2/a3 | 1,27 (±0.12) | 1,16 (±0.1) | 0,85 (±0.05) |
2.3. Shared procedures
2.3.1. EEG recordings
All recordings were obtained in the morning with subjects resting comfortably. Vigilance was continuously monitored in order to avoid drowsiness.
The EEG activity was recorded continuously from 19 sites by using electrodes set in an elastic cap (Electro-Cap International, Inc.) and positioned according to the 10-20 International system (Fp1, Fp2, F7, F3, Fz, F4, F8, T3, C3, Cz, C4, T4, T5, P3, Pz, P4, T6, O1, O2). The ground electrode was placed in front of Fz. The left and right mastoids served as reference for all electrodes. The recordings were used off-line to re-reference the scalp recordings to the common average. Data were recorded with a band-pass filter of 0.3-70 Hz, and digitized at a sampling rate of 250 Hz (BrainAmp, BrainProducts, Germany). Electrodes-skin impedance was set below 5 kW. Horizontal and vertical eye movements were detected by recording the electrooculogram (EOG). The recording lasted 5 minutes, with subjects with closed eyes. Longer recordings would have reduced the variability of the data, but they would also have increased the possibility of slowing of EEG oscillations due to reduced vigilance and arousal. EEG data were then analyzed and fragmented off-line in consecutive epochs of 2 seconds, with a frequency resolution of 0.5 Hz. The average number of epochs analyzed was 140 ranging from 130 to150. The EEG epochs with ocular, muscular and other types of artifacts were discarded.
2.3.2. Analysis of individual frequency bands
A digital FFT-based power spectrum analysis (Welch technique, Hanning windowing function, no phase shift) computed – ranging from 2 to 45 Hz – the power density of EEG rhythms with a 0.5 Hz frequency resolution. Methods are exposed in detail elsewhere (Moretti et al., 2004, 2007a,b]. Briefly, two anchor frequencies were selected according to literature guidelines (Klimesch et al., 1999), that is, the theta/alpha transition frequency (TF) and the individual alpha frequency (IAF) peak. Based on TF and IAF, we estimated the following frequency band range for each subject: delta, theta, low alpha band (alpha1 and alpha2), and high alpha band (alpha3). Moreover, individual beta and gamma frequencies were computed. Three frequency peaks were detected in the frequency range from the individual alpha 3 frequency band and 45 Hz. These peaks were named beta1 peak (IBF 1), beta2 peak (IBF 2) and gamma peak (IGF). Based on peaks, the frequency ranges were determined. Beta1 ranges from alpha 3 to the lower spectral power value between beta1 and beta2 peak; beta2 frequency ranges from beta 1 to the lower spectral power value between beta2 and gamma peak; gamma frequency ranges from beta 2 to 45 Hz, which is the end of the range considered. The mean frequency range computed in MCI subjects considered as a whole are: delta 2.9-4.9 Hz; theta 4.9-6.9 Hz; alpha1 6.9-8.9 Hz; alpha2 8.9-10.9 Hz; alpha3 10.9-12-9 Hz; beta1 12,9-19,2 Hz; beta2 19.2-32.4; gamma 32.4-45. In the frequency bands determined in this way, the relative power spectra for each subject were computed. The relative power density for each frequency band was computed as the ratio between the absolute power and the mean power spectra from 2 to 45 Hz. Th9 relative band power at each band was defined as the mean of the relative band power for each frequency bin within that band. Finally, the theta/gamma and alpha3/alpha2 relative power ratio were computed and analyzed. The analysis of other frequencies was not in the scope of this study.
2.3.3. Diagnostic criteria
In this study we enrolled subjects afferents to the scientific institute of research and cure Fatebenefratelli in Brescia, Italy. Patients were taken from a prospective project on clinical progression of MCI. The project was aimed to study the natural history of non demented persons with apparently primary cognitive deficits, not caused by psychic (anxiety, depression, etc.) or physical (uncontrolled heart disease, uncontrolled diabetes, etc.) conditions. Patients were rated with a series of standardized diagnostic tests, including the Mini-Mental State Examination (MMSE; Folstein et al., 1975), the Clinical Dementia Rating Scale (CDRS; Hughes et al., 1982), the Hachinski Ischemic Scale (HIS; Rosen et al., 1980), and the Instrumental and Basic Activities of Daily Living (IADL, BADL, Lawton and Brodie, 1969). In addition, patients were subjected to diagnostic neuroimaging procedures (magnetic resonance imaging, MRI) and laboratory blood analysis to rule out other causes of cognitive impairment.
The present inclusion and exclusion criteria for MCI were based on previous seminal studies (Albert et al., 1991; Petersen et al., 1995, 1997, 2001; Portet et al., 2006; Geroldi et al., 2006). Inclusion criteria in the study were all of the following: (i) complaint by the patient or report by a relative or the general practitioner of memory or other cognitive disturbances; (ii) mini mental state examination (MMSE; Folstein et al., 1975) score of 24 to 27/30 or MMSE of 28 and higher plus low performance (score of 2/6 or higher) on the clock drawing test (Shulman, 2000); (iii) sparing of instrumental and basic activities of daily living or functional impairment stably due to causes other than cognitive impairment, such as physical impairments, sensory loss, gait or balance disturbances, etc. Exclusion criteria were any one of the following: (i) age of 90 years and older; (ii) history of depression or psychosis of juvenile onset; (iii) history or neurological signs of major stroke; (iv) other psychiatric diseases, epilepsy, drug addiction, alcohol dependence; (v) use of psychoactive drugs including acetylcholinesterase inhibitors or other drugs enhancing brain cognitive functions; and (vi) current or previous uncontrolled or complicated systemic diseases (including diabetes mellitus) or traumatic brain injuries.
All patients underwent: (i) semi-structured interview with the patient and – whenever possible – with another informant (usually the patient’s spouse or a child) by a geriatrician or neurologist; (ii) physical and neurological examinations; (iii) performance-based tests of physical function, gait and balance; (iv) neuropsychological assessment evaluating verbal and non-verbal memory, attention and executive functions (Trail Making Test B-A; Clock Drawing Test; Amodio et al., 2000; Shulman, 2000), abstract thinking (Raven matrices; Basso et al., 1987), frontal functions (Inverted Motor Learning; Spinnler and Tognoni, 1987); language (Phonological and Semantic fluency; Token test; Carlesimo et al., 1996), and apraxia and visuo-constructional abilities (Rey figure copy; Caffarra et al., 2002); (v) assessment of depressive symptoms with the Center for Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977). Given the aim of the study to evaluate the impact of vascular damage on EEG rhythms, in this study we did not consider the clinical subtype of MCI, i.e. amnesic, non amnesic or multiple domain.
2.4. Magnetic resonance imaging (MRI) and CV damage evaluation
Magnetic Resonance (MR) images were acquired using a 1.0 Tesla Philips Gyroscan. Axial T2 weighted, proton density (DP) and fluid attenuated inversion recovery (FLAIR) images were acquired with the following acquisition parameters: TR = 2000 ms, TE = 8.8/110 ms, flip angle = 90°, field of view = 230 mm, acquisition matrix 256x256, slice thickness 5 mm for T2/DP sequences and TR = 5000 ms, TE = 100 ms, flip angle = 90°, field of view = 230 mm, acquisition matrix 256x256, slice thickness 5 mm for FLAIR images.
Subcortical cerebrovascular disease (sCVD) was assessed using the rating scale for age-related white matter changes (ARWMC) on T2-weighted and FLAIR MR images. White matter changes (WMC) was rated by a single observer (R.R.) in the right and left hemispheres separately in frontal, parieto-occipital, temporal, infratentorial areas and basal ganglia on a 4 point scale. The observer of white matter changes was blind to the clinical information of the subjects. Subscores of 0, 1, 2, and 3 were assigned in frontal, parieto-occipital, temporal, infratentorial areas for: no WMC, focal lesions, beginning confluence of lesions, and diffuse involvement of the entire region, respectively. Subscores of 0, 1, 2, and 3 were assigned in basal ganglia for: no WMC, 1 focal lesion, more than 1 focal lesion and confluent lesions, respectively. Total score was the sum of subscores for each area in the left and right hemisphere, ranging from 0 to 30. As regards the ARWMC scale, the interrater reliability, as calculated with weighted k value, was 0.67, indicative of moderate agreement (Wahlund et al., 2001). We assessed test-retest reliability on a random sample of 20 subjects. The intraclass correlation coefficient was 0.98, values above 0.80 being considered indicative of good agreement.
Based on increasing subcortical CV damage, the 99 MCI subjects were subsequently divided in 4 sub-groups along the range between the minimum and maximum ARWMC score (respectively 0 and 15). In order to have the higher sensibility to the CV damage, the first group was composed by subjects with score = 0. The other groups were composed according to equal range ARWMC scores. As a consequence, we obtained the following groups: group 1 (G1) no vascular damage, CV score 0; group 1 (G2), mild vascular damage, CV score 1-5; group 3 (G3), moderate vascular damage, CV score 6-10; group 1 (G4), severe vascular damage, CV score 11-15.
Table 1 reports the mean values of demographic and clinical characteristics of the 4 subgroups.
2.5. Statistical analysis
Preliminarly, any significant difference between groups in demographic variables, age, education and gender as well as MMSE score was taken into account. Only education showed a significant differences between groups (p<0.03). For avoiding confounding effect, subsequent statistical analyses of variance (ANOVA) were carried out using age, education, gender and MMSE score as covariates. Duncan’s test was used for post hoc comparisons. For all statistical test the significance was set to p<0.05.
A second session of ANOVA was performed on EEG relative power data. In this analysis, Group factor was the independent variable and frequency band power (delta, theta, alpha1, alpha2, alpha3) the dependent variable.
As successive step, to evaluate the presence of EEG indexes that correlate specifically with vascular damage, we performed statistical analyses to evaluate the specificity of the following ratios: theta/alpha1, using as covariate also TF; alpha2/alpha3 using as covariate also IAF and alpha1/alpha2 with both TF and IAF as covariate. Moreover, we performed correlations (Pearson’s moment correlation) between CV damage score and frequency markers (TF and IAF), spectral power, and MMSE. Finally, we performed a control statistical analysis with 4 frequency bands, considering alpha1 and alpha2 as single band (low alpha). This analysis had the aim to verify if the low alpha, when considered as a whole, has the same behavior.
3. Results
Figure 1 displays the results for ANOVA analysis of these data showing a significant interaction between Group and Band factors [F (12.380)= 2.60); p < 0.002]. Interestingly, Duncan post hoc showed a significant decrease of delta power in G1 compared to G4 (p < 0.050) and a significant increase in alpha2 power in G1 compared to G3 and G4 (p < 0.000). On the contrary, no differences were found in theta, alpha1 and alpha 3 band power. Moreover, a closer look at the data, in respect to the alpha1 frequency, showed a decrease proportional to the degree of CV damage very similar to alpha2 band, although not significant. On the contrary, in the alpha3 band power this trend was not present, suggesting that vascular damage had no impact on this frequency band.
The correlation analysis between CV score and spectral band power showed a significant positive correlation with delta power (r= 0.221; p < 0.03), a significant negative correlation with alpha1 (r= -0.312; p < 0.002) and alpha2 power (r -0.363; p < 0.0003). The correlations between CV score with theta power (r= 0.183; p = 0.07) and alpha3 power (r= -0.002; p = 0.93) were not significant as well as the correlation between CV score and MMSE (r= -0.07; p= 0.4).
Table 3 displays the values of the theta/alpha1 and alpha2/alpha3 power ratio. The statistical analysis of the theta/alpha1 ratio showed a main effect of Group [F (3.91)=15.51; p < 0.000]. Duncan post hoc testing showed a significant increase of the theta/alpha1 ratio between G1 and G2 respect to G3 and G4 (p < 0.000). Moreover, the increase of this ratio was significant also between G3 and G4 (p<0.04). The statistical analysis of the alpha2/alpha3 power ratio showed a main effect of Group [F (3.91)=4.60; p < 0.005]. Duncan post hoc testing showed a significant decrease of the ratio between G1 and G3 (p < 0.02), G1 and G4 (p < 0.010) and between G2 and G4 (p < 0.05). The statistical analysis of the alpha1/alpha2 ratio did not show the main effect of Group (p < 0.2).
79 (42/37) | 27 (14/13) | 27 (15/12) | 25 (13/12) | |||
69.2±2.3 | 66.8±6.8 | 69.4±8.7 | 71.5±6.9 | 0.1 | ||
7.7±0.8 | 8.3±4.5 | 6.7±3.1 | 8.2±4.6 | 0.2 | ||
27.1±0.4 | 27.5±1.5 | 27.4±1.5 | 26.6±1.8 | 0.1 | ||
6965.3±1248.8 | 8151.2±436.4 | 7082.7±266.9 | 5661.8±720.4 | 0.00001 | ||
4891.7±902.6 | 5771.6±361.1 | 4935.6±380.9 | 3967.9±650.3 | 0.00001 | ||
2073.5±348.7 | 2379.6±321.3 | 2147.1±301.3 | 1693.9±288.5 | 0.0001 | ||
4889.8±962.4 | 5809.6±314.2 | 4969.4±257.6 | 3890.1±551.4 | 0.00001 | ||
2071.7±446.4 | 2514.4±259.5 | 2079.2±122.8 | 1621.6±185.2 | 0.0001 | ||
3.8±0.5 | 3.2±2.8 | 4.2±3.8 | 4.1±3.6 | 0.7 |
3.1. MRI scans and amygdalo-hippocampal atrophy evaluation
MRI scans were acquired with a 1.0 Tesla Philips Gyroscan at the Neuroradiology Unit of the Città di Brescia hospital, Brescia. The following sequences were used to measure hippocampal and amygdalar volumes: a high-resolution gradient echo T1-weighted sagittal 3D sequence (TR = 20 ms, TE = 5 ms, flip angle = 30°, field of view = 220 mm, acquisition matrix = 256 x 256, slice thickness = 1.3 mm), and a fluid-attenuated inversion recovery (FLAIR) sequence (TR = 5000 ms, TE = 100 ms, flip angle = 90°, field of view = 230 mm, acquisition matrix = 256 x 256, slice thickness = 5 mm). Hippocampal, amygdalar and white matter hyperintensities (WMHs) volumes were obtained for each subject. The hippocampal and amygdalar boundaries were manually traced on each hemisphere by a single tracer with the software program DISPLAY (McGill University, Montreal, Canada) on contiguous 1.5 mm slices in the coronal plane. The amygdala is an olive-shaped mass of gray matter located in the superomedial part of the temporal lobe, partly superior and anterior to the hippocampus. The starting point for amygdala tracing was at the level where it is separated from the entorhinal cortex by intrarhinal sulcus, or tentorial indentation, which forms a marked indent at the site of the inferior border of the amygdala. The uncinate fasciculus, at the level of basolateral nuclei groups, was considered as the anterior-lateral border. The amygdalo-striatal transition area, which is located between lateral amygdaloid nucleus and ventral putamen, was considered as the posterior-lateral border. The posterior end of amygdaloid nucleus was defined as the point where gray matter starts to appear superior to the alveolus and laterally to the hippocampus. If the alveolus was not visible, the inferior horn of the lateral ventricle was employed as border (Moretti et al., 2008). The starting point for hippocampus tracing was defined as the hippocampal head when it first appears below the amygdala, the alveus defining the superior and anterior border of the hippocampus. The fimbria was included in the hippocampal body, while the grey matter rostral to the fimbria was excluded. The hippocampal tail was traced until it was visible as an oval shape located caudally and medially to the trigone of the lateral ventricles (Moretti et al., 2007a,b). The intraclass correlation coefficients were 0.95 for the hippocampus and 0.83 for the amygdala.
White matter hyperintensities (WMHs) were automatically segmented on the FLAIR sequences by using previously described algorithms (Moretti et al., 2007a,b). Briefly, the procedure includes (i) filtering of FLAIR images to exclude radiofrequency inhomogeneities, (ii) segmentation of brain tissue from cerebrospinal fluid, (iii) modelling of brain intensity histogram as a gaussian distribution and (iv) classification of the voxels whose intensities were ≥3.5 SDs above the mean as WMHs (Moretti et al., 2007a,b) Total WMHs volume was computed by counting the number of voxels segmented as WMHs and multiplying by the voxel size (5 mm3). To correct for individual differences in head size, hippocampal, amygdalar and WMHs volumes were normalized to the total intracranial volume (TIV), obtained by manually tracing with DISPLAY the entire intracranial cavity on 7 mm thick coronal slices of the T1 weighted images. Both manual and automated methods user here have advantages and disadvantages. Manual segmentation of the hippocampus and amygdala is currently considered the gold standard technique for the measurement of such complex structures. The main disadvantages of manual tracing are that it is operator dependent and time consuming. Conversely, automated techniques are more reliable and less time-consuming, but may be less accurate when dealing with structures without clearly identifiable borders. This however is not the case for WMHs which appear as hyperintense on FLAIR sequences.
Left and right hippocampal as well as amygdalar volumes were estimated and summed to obtain a total volume (individual) of both anatomical structures. In turn, total amygdalar and hippocampal volume were summed obtaining the whole AHC volume. AHC (whole) volume has been divided in tertiles obtaining three groups. In each group hippocampal and amygdalar volume (within AHC) has been computed. The last volumes were compared with the previous obtained individual (hippocampal and amygdalar) volumes.
3.2. Statistical analysis and data management
The analysis of variance (ANOVA) has been applied as statistical tool. At first, any significant differences among groups in demographic variables, i.e., age, education, MMSE score, and morphostructural characteristics, i.e., AHC, hippocampal, amygdalar and white matter hyperintensities (WMHs) volume were evaluated (table 1). Greenhouse-Geisser correction and Mauchley’s sphericity test were applied to all ANOVAs. In order to avoid a confounding effect, ANOVAs were carried out using age, education, MMSE score, and WMHs as covariates. Duncan’s test was used for post-hoc comparisons. For all statistical tests the significance level was set at p<0.05.
At first, we choose to focus the changes of brain rhythmicity induced from hippocampal atrophy alone.,Subjects were subdivided in four groups based on hippocampal volume of a normal, control sample matched for age, sex and education as compared to the whole MCI group. In the normal group the ratio female/male was 93/46, mean age was 68.9 (SD ±10.3) mean education years 8.9 (SD ±9.4). The mean and standard deviation of the hippocampal volume in the normal old population of 139 subjects were 5.72 ± 1.1 cm3. In this way, 4 groups were obtained: the no atrophy group with hippocampal volume equal or superior to the normal mean (total hippocampal volume from 6.79 cm3 to 5.75 cm3; G1); the mild atrophy group which has hippocampal volume within 1.5 SD below the mean of hippocampal normal control value (total hippocampal volume from 5.70 to 4.70 cm3; G2); the moderate atrophy group which has hippocampal volume between 1.5 and 3 SD below the mean of normal hippocampus (total hippocampal volume from 4.65 to 3.5 cm3; G3); and the severe atrophy group which has hippocampal volume between 3 and 4.5 SD below the mean of hippocampal normal control volume (total hippocampal volume from 3.4 to 2.53 cm3; G4). The rationale for the selection of 1,5 SD was to obtain reasonably pathological groups based on hippocampal volume. A SD below 1.5 could recollect still normal population based on hippocampal volume. On the other side, a SD over 1.5 could not allow an adequate size of all subgroups in study.
Subsequently, ANOVA was performed in order to verify 1) the difference of AHC volume among groups; 2) the difference of hippocampal and amygdalar volume within AHC among groups; 3) the difference of hippocampal and amygdalar volume individually considered among groups; 4) NPS impairment based on ACH atrophy.
Moreover, as a control analysis, in order to detect if difference in EEG markers was linked to significant difference in volume measurements, the volume of hippocampus within AHC was compared with the hippocampal volume individually considered, as well as the amygdalar volume within AHC was compared with the amygdalar volume individually considered. This control analysis was performed through a paired t-test.
Subsequently, ANOVA was performed in order to check differences in theta/gamma and alpha3/alpha2 relative power ratio in the three groups ordered by decreasing tertile values of the whole AHC volume. In each ANOVA, group was the independent variable, the frequency ratios was the dependent variable and age, education, MMSE score, and WMHs was used as covariates. Duncan’s test was used for post-hoc comparisons. For all statistical tests the significance level was set at p<0.05.
In order to check closer association with EEG markers, hippocampal volume, and amygdalar volume within AHC were analyzed separately. A control analysis was carried out also on the individual hippocampal and amygdalar volumes based on decreasing tertile values for homogeneity with the main analysis.
4. Results
Figure 2 displays the results for ANOVA analysis performed on 4 groups of MCI considering growing values of hippocampal atrphy. The results show a significant interaction between Group and Band power [F (12,336)= 2,36); p < 0.007]. Duncan post hoc showed that G3 group has the highest alpha2 and alpha3 power statistically significant with respect to all other groups (p<0.05; p< 0.006 respectively). The same trend was present in the subsidiary ANOVA. These results show that the relationship between hippocampal atrophy and EEG relative power is not proportional to the hippocampal atrophy and highlight that the group with a moderate hippocampal volume had a particular pattern of EEG activity as compared to all other groups.
Table 2 summarizes the ANOVA results of demographic variables, i.e., age, education, MMSE score, and morphostructural characteristics, i.e., hippocampal, amygdalar and white matter hyperintensities volume in the whole MCI cohort as well as in the three subgroups in study. Hippocampal and aymgdalar volumes are considered as parts of the whole AHC volume as well as individually considered. Significant statistical results were found in hippocampal and amygdalar volume both within the AHC (respectively, F2,76=92.74; p<0.00001 and F2,76=33.82; p<0.00001) and individually considered (respectively, F2,76=157.27; p<0.00001 and F2,76=132.5; p<0.00001). The global AHC volume also showed significant results (F2,76=159.27; p<0.00001). Duncan’s post-hoc test showed a significant increase (p< 0.01) in all comparisons. The paired t-test showed significant difference between the volume of ACH-amygdala vs amygdalar volume individually considered in the first group (p <0.03). The amygdalar volume difference in the other groups (respectively p=0.2 and 0.1) as well as the difference in the volume of AHC-hippocampus vs individual hippocampus (p= 0.4 in the first, p=0.5 in the second and p=0.1 in the third group) was not statistically significant.
Table 3 and 4 shows the results of theta/gamma and alpha3/alpha2 ratio in the groups based on the decrease of whole AHC volume as well as, within the same group, the decrease of hippocampal and amygdalar volumes separately considered. ANOVA shows results towards significance when amygdalo-ippocampal volume is considered globally both in theta/gamma (F2,76 =2.77; p<0.06) and alpha3/alpha2 ratio (F2,76 =2.71; p<0.07). When amygdalar and hippocampal volumes were considered separately, ANOVA results revealed significant main effect Group, respectively, in theta/gamma ratio analysis (F2,76 =3.46; p<0.03) for amygdalar and alpha3/alpha2 ratio for hippocampal (F2,76=3.38; p<0.03) decreasing volume. The ANOVA did not show significant results in theta/gamma ratio when considering hippocampal volume (F2,76=0.3; p<0.7) and in alpha3/alpha2 ratio when considering amygdalar volume (F2,76=1.46; p<0.2). The control analysis (individual volumes) did not show any significant result neither for hippocampal (theta/gamma, F2,76=0.3; p<0.7; alpha3/alpha2, F2,76=2.15; p<0.1) nor for amygdalar volume (theta/gamma, F2,76=0.76; p<0.4; alpha3/alpha2, F2,76=2.15; p<0.1).
Group1 | 1.40±0.35 | 0.06 | 1.05±0.11 | 0.07 |
Group2 | 1.43±0.35 | 1.11±0.14 | ||
Group3 | 1.47±0.44 | 1.12±0.16 | ||
Group1 | 1.39±0.27 | 0.7 | 1.04±0.11 | 0.03 |
Group2 | 1.48±0.45 | 1.11±0.15 | ||
Group3 | 1.43±0.41 | 1.12±0.14 | ||
Group1 | 1.36±0.37 | 0.03 | 1.04±0.13 | 0.2 |
Group2 | 1.44±0.36 | 1.12±0.16 | ||
Group3 | 1.49±0.39 | 1.09±0.11 | ||
Group1 | 1.39±0.27 | 0.7 | 1.04±0.11 | 0.1 |
Group2 | 1.48±0.45 | 1.07±0.15 | ||
Group3 | 1.43±0.40 | 1.10±0.14 | ||
Group1 | 1.39±0.37 | 0.1 | 1.04±0.13 | 0.4 |
Group2 | 1.43±0.36 | 1.12±0.16 | ||
Group3 | 1.46±0.39 | 1.09±0.11 |
4.1. Clinical and neurophsyiological remarks
4.1.1. MCI and EEG markers: degenerative versus vascular impairment
A large body of literature has previously demonstrated that in subjects with cognitive decline is present an increase of theta relative power (Moretti et al 2007a,b, 2008), a decrease of gamma relative power (Stam et al., 2003, Moretti et al., 2007a,2007b 2008) as well as an increase of high alpha as compared to low alpha band (Moretti et al., 2008). On the whole theta/gamma ratio and alpha3/alpha2 ratio could be considered reliable EEG markers of cognitive decline.
The amygdalo-hippocampal network is a key structure in the generation of theta rhythm. More specifically, theta synchronization is increased between LA and CA1 region of hippocampus during long-term memory retrieval, but not during short-term or remote memory retrieval (Seidenbecher et al., 2003; Narayanan et al., 2007). In particular, the AHC is critically involved in the formation and retention of fear memories (Narayanan et al., 2007). Theta synchronization in AHC appears to be a neural correlate of fear, apt to improve the neural communication during memory retrieval (Narayanan et al., 2007). On the other hand, the retrieval of hippocampus-dipendent memory is provided by the integrity of CA3-CA1 interplay coordinated by gamma oscillations (Montgomery and Buzsaki, 2007). Our results confirm and extends all previous findings. The atrophy of AHC determines increasing memory deficits. The brain oscillatory activity of this MCI state is characterized by an increase of theta/gamma ratio and alpha3/alpha2 relative power ratio, confirming the overall reliability of these EEG markers in cognitive decline. Our results suggest that theta synchronization is mainly due to the amygdala activation or as a subsequent final net effect within the AHC functioning driven by the amygdala excitation. The increase in theta activities in AHC, representing an increase in neuronal communication apt to promote or stabilize synaptic plasticity in relation to the effort to retention of associative memories (Sauseng et al., 2004), could be active also during an ongoing degenerative process. The excitation mechanism could be facilitated by the loss of GABA inhibitory process, determining the decrease of gamma rhythm generation (Bragin et al., 1995; Montgomery and Buzsaki, 2007).
As regards the CV damage, our results showed that the CV damage affected both delta and low alpha band power (alpha1 and alpha2). In the delta band we observed a power increase proportional to the CV damage, with a significant increase in the group with severe CV damage, as compared to the no-CV-damage group. The impact of the CV damage on the delta power was confirmed by the significant positive correlation between CV damage score and delta power itself.
The increase in the delta band power could be explained as a progressive cortical disconnection due to the slowing of the conduction along cortico-subcortical connecting pathways.
This result confirmed the increase in the delta band power we had observed in CV patients, as compared to normal elderly subjects (Moretti et al., 2004). It is to be noted that the increase in the delta band power reflects a global state of cortical deafferentation, due to various anatomofunctional substrates, such as stages of sleep, metabolic encephalopathy or cortico-thalamocortical dysrhythmia (Llinas et al., 1999). In the low a band power, we observed a significant decrease in the a2 band power for the groups with moderate and severe CV damage, as compared to the no-CV-damage group. In the a1 frequency band, there was a similar decrease although it did not reach statistically significant values. These results were confirmed by a correlation analysis which showed a significant negative correlation between CV damage score and a1 and a2 band powers. In our results, the CV damage did not show any impact on the a3 (or high a) power. This is a confirmation of what we found in the previous study, where no differences between VaD patients and normal elderly (but not in AD vs normal elderly) subjects were detected in the a3 power.
Together, these results could suggest different generators for low a and high a frequency bands. In particular, the low a band power could affect cortico-subcortical mechanisms, such as cortico-thalamic, cortico-striatal and cortico-basal ones. This could explain the sensitivity of the low a frequency band to subcortical vascular damage. On the contrary, the a3 band power could affect to a greater extent those cortico-cortical interactions based on synaptic efficiency prone to degenerative rather than CV damages (Klimesch, 1999; Klimesch et al., 2007). In order to find reliable indices of CV damage, we checked the theta/a1 band power ratio. Previous studies have shown the reliability of this kind of approach in quantitative EEG in demented patients (Jelic et al., 1997). The importance of this ratio lies in the presence of such frequency bands on the opposite side of the TF, that is, the EEG frequency index most significantly affected by the CV damage. So, the theta/a1 band power ratio could represent the most sensitive EEG marker of CV damage. The results showed a significant increase of the theta/a1 band power ratio in moderate and severe CV damage groups, as compared to mild and no-CV-damage groups. This ratio increase establishes a proportional increase of the theta band power relative to the a1 band power with respect to the CV damage, even though a significant increase in the h band power per se (or a decrease in the a1 band power per se) is not present. This could suggest a reliable specificity for the theta/a1 band power ratio in focusing the presence of a subcortical CV damage.
4.1.2. MCI, cognitive deficits (memory and attention) and EEG activity
The vulnerability and damage of the connections of hippocampus with amygdala could affect reconsolidation of long-term memory and give rise to memory deficits and behavioural symptoms. Several experiments shows that amygdala activity is prominent during period of intense arousal, e.g. the anticipation of a noxious stimulus (Parè et al., 2002) or the maintenance of vigilance to negative stimuli (Garolera et al., 2007). So far, the theta synchronization induced by the amygdala is deeply involved in endogenous attentional mechanism. Interestingly, the increase of high alpha synchronization has been found in internally-cued mechanisms of attention, associated with inhibitory top-down processes (Klimesch, 2007). Of note, the amygdala is intimately involved in the anatomo-physiological anterior pathways of attention through its connections with anterior cingulated cortex, anteroventral, anteromedial and pulvinar thalamic nuclei (Young et al., 2007). The particular role of amygdala in negative human emotions could indicate that AHC atrophy is associated with excessive level of subcortical inputs not adequately filtered by attentive processing, determining fear and anxiety and generating cognitive interference in memory performance. Of note, an altered emotional response is very frequent in MCI patients (Ellison et al., 2008, Rozzini et al., 2008). In a feed-back process, this alteration could determine a general state of “hyperattention” during which top-down internal processes prevail on the bottom-up phase, altering attention mechanism and preventing a correct processing of sensory stimuli. Focused attention has been found impaired in MCI patients in particular when they have to benefit from a cue stimulus (Johanssen et al., 1999; Berardi et al., 2005 ; Levinoff et al., 2005 Tales et al. 2005a, 2005b). This particular state could be useful for maintain a relatively spared global cognitive performance, whereas it could fail when a detailed analysis of a sensory stimulus is required. This “hyperattentive” state could represent the attempt to recollect memory and/or spatial traces from hippocampus and to combine them within associative areas connected with hippocampus itself.
The increase of alpha3/alpha2 ratio in our results support the concomitance of anterior attentive mechanism impairment in subject with MCI, even though there are not overt clinical deficits. The mayor association of the increase of alpha3/alpha2 ratio with the hippocampal formation within the AHC, suggest that this filter activity is carried out by hippocampus and its input-output connections along anterior attentive circuit and AHC. Interestingly, a recent work has demonstrated that the mossy fiber (MF) pathway of the hippocampus connects the dentate gyrus to the auto-associative CA3 network, and the information it carries is controlled by a feedforward circuit combining disynaptic inhibition with monosynaptic excitation. Analysis of the MF associated circuit revealed that this circuit could act as a highpass filter (Zalay and Bardakjian, 2006).
The natural history of a group of subjects at very high-risk for developing dementia due to subcortical vascular damage [subcortical vascular MCI (svMCI)] has recently been described (Frisoni et al., 2002; Galluzzi et al., 2005). In such study, MCI patients with CV etiology developed a distinctive clinical phenotype characterized by poor performance on frontal tests, and neurological features of parkinsonism without tremor (impairment of balance and gait).These clinical features could be explained by our results. In CV patients, we observed a slowing of the a frequency in the two groups with greater CV damage, as compared to the groups with lesser CV damage. This is in line with a previous study (Moretti et al., 2004) showing that the major effect of the CV damage, in patients with vascular dementia (VaD) vs normal elderly and Alzheimer’s patients. A reasonable (although speculative) explanation of the present results is that the CV damage-induced slowing of the a frequency start point could be mainly attributed to the lowering of the conduction time of synaptic action potentials throughout cortico-subcortical fibers, such as cortico-basal or cortico-thalamic pathways (Steriade and Llinas, 1988). In fact, experimental models have previously shown that the EEG frequency is due to axonal delay and synaptic time of cortico-subcortical interactions (Lopes da Silva et al., 1976; Nunez et al., 2001; Doiron et al., 2003). Most interestingly, other studies have demonstrated that fiber myelination affects the speed propagation along cortical fibers, and that this parameter is strictly correlated to the frequency range recorded on the scalp. In fact, a theoretical model considering a mean speed propagation in white matter fibers of 7.5 m/s (together with other parameters) is associated with a fundamental mode frequency of 9 Hz (Nunez and Srinivasan, 2006), that is, the typical mode of scalp-recorded EEG. It is to be noted that a correlation between white matter damage and widespread slowing of EEG rhythmicity was found in other studies, following the presence of cognitive decline (Szelies et al., 1999), multiple sclerosis (Leocani et al., 2000), or cerebral tumors (Goldensohn, 1979). In order to find reliable indices of CV damage, we checked the theta/a1 band power ratio. Previous studies have shown the reliability of this kind of approach in quantitative EEG in demented patients (Jelic et al., 1997). The importance of this ratio lies in the presence of such frequency bands on the opposite side of the TF, that is, the EEG frequency index most significantly affected by the CV damage. So, the theta/a1 band power ratio could represent the most sensitive EEG marker of CV damage. The results showed a significant increase of the theta/a1 band power ratio in moderate and severe CV damage groups, as compared to mild and no-CV-damage groups. This ratio increase establishes a proportional increase of the theta band power relative to the a1 band power with respect to the CV damage, even though a significant increase in the theta band power per se (or a decrease in the a1 band power per se) is not present. This could suggest a reliable specificity for the theta/alpha1 band power ratio in focusing the presence of a subcortical CV damage.
References
- 1.
Albert M. Smith L. A. Scherr P. A. Taylor J. O. Evans D. A. Funkenstein H. H. 1991 Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer’s disease. Int J Neurosci 57, (3-4):167-78. - 2.
Amodio P. Wenin H. Del Piccolo F. Mapelli D. Montagnese S. Pellegrini A. Musto C. Gatta A. Umiltà C. 2002 Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin Exp Res14 117 131 - 3.
The topographical and neuroanatomical distribution od neurofibrillaty tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb CortexArnold S. E. Hyman B. T. Flory J. Damasco A. R. Van Hoesen G. W. 1991 1 103 116 - 4.
Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: a multi-centric study. Clin NeurophysiolBabiloni C. Binetti G. Cassetta E. Dal Forno. G. Del Percio C. Ferreri F. Ferri R. Frisoni G. Hirata K. Lanuzza B. Miniussi C. Moretti D. V. Nobili F. Rodriguez G. Romani G. L. Salinari S. Rossini P. M. 2006 a 117 2 252 68 - 5.
Basso A. Capitani E. Laiacona M. 1987 Raven’s coloured progressive matrices: normative values on 305 adult normal controls. Funct Neurol2 189 194 - 6.
Bennett DA, Schneider JA, Bienais JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology,2004 23 325 335 - 7.
Sustained attentino in mild Alzheimer’s disease. Dev NeuropsycholBerardi A. M. Parasuraman R. Haxby J. V. 2005 58 507 537 - 8.
DementiaBobinski M. Wegiel J. Wisniewski H. M. Tarnawski M. Reisberg B. Mlozidc B. et al. Atrophy of. hippocampal formation. subdivisions correlates. with stage. duration of. Alzheimer’s disease. 1995 6 205 210 - 9.
Journal of neuroscienceBragin A. Jando G. Nadasdy Z. Hetke J. Wise K. Buzsaki G. Gamma (40-1. Hz oscillation. in the. hippocampus of. the behaving. rat 1995 15 47 60 - 10.
Caffarra P. Vezzadini G. Dieci F. Zonato F. Venneri A. 2002 Rey- Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci22 443 437 - 11.
NeurologyCallen Dj. Black S. E. Gao F. Caldwell C. B. Szalai J. P. Beyond the. hippocampus M. R. I. volumetry confirms. widespread limbic. atrophy in. A. D. 2001 57 1669 1674 - 12.
Carlesimo G. A. Caltagirone C. Gainotti G. 1996 The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol36 378 384 - 13.
The rhinal cortices : a wall of inhibitio between the neocortex and the hippocampus. Progress in neurobiologyDe Curtis M. Parè D. 2004 74 101 110 - 14.
An empirical comparison of SPM preprocessing parameters to the analysis of fMRI data. NeuroimageDella Maggiore V. Chau W. Peres-Neto P. R. Mc Intosh A. R. 2002 19 28 - 15.
Medial temporal lobe function and structure in midl cognitive impairment. Ann NeurolDickerson B. C. Salat D. H. Bates J. F. Atiya M. Kiliiany R. J. Greve D. N. et al. 2004 56 27 35 - 16.
NeurologyDickerson B. C. Salat D. H. Greve D. N. Chua E. F. Rand-Giovannetti E. Rentz D. M. et al. Increased hippomcapal. activation in. midl cognitive. impairment compared. to normal. aging A. D. 2005 65 404 411 - 17.
Inhibitory feedback required for network oscillatory responses to communication but not prey stimuli. NatureDoiron B. MJ Chacron Maler. L. Longtin L. Bastian J. 2003 421 538 43 - 18.
magnetic resonance imaging of the enthorinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg PsychiatryDu A. T. Schuff N. Amend D. Laasko M. P. Hsu Y. Y. Jagust W. J. et al. 2001 71 441 7 - 19.
CNS Spectr.Ellison J. M. Harper D. G. Berlow Y. Zeranski L. Beyond the. . C. in M. C. I. noncognitive symptoms. in amnestic. non-amnestic mild. cognitive impairment. C. N. 2008 Jan;13 1 66 72 - 20.
Motor cortex excitability in Alzheimer’s disease: a transcranial magnetic stimulation study. Ann Neurol.Ferreri F. Pauri F. Pasqualetti P. Fini R. Dal Forno. G. Rossini P. M. 2003 Jan;53 1 102 8 - 21.
Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991;Flicker C. S. Ferris H. Reisberg B. 41 1006 9 etersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid SN, Thibodeau SN, Kokmen E, Waring SC, Kurland LT. Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memoryimpaired individuals. J Am Med Assoc1995 - 22.
Folstein MF, Folstein SE, McHugh PR 1975 Mini mental state’: a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res12 189 98 - 23.
Mild cognitive impairment with subcortical vascular features: Clinical characteristics and outcome. J NeurolFrisoni G. B. Galluzzi S. Bresciani L. Zanetti O. Geroldi C. 2002 249 1423 1432 - 24.
Mild cognitive impairment with subcortical vascular features: Clinical characteristics and outcome. J NeurolFrisoni G. B. Galluzzi S. Bresciani L. Zanetti O. Geroldi C. 2002 249 1423 1432 - 25.
In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer’s disease. J Neurol.Frisoni G. B. Prestia A. Rasser P. E. Bonetti M. Thompson P. M. 2009 Feb 28. [Epub ahead of print] - 26.
Distinctive Clinical Features of Mild Cognitive Impairment with Subcortical CV Disease. Dement Geriatr Cogn DisordGalluzzi S. Sheu C. F. Zanetti O. Frisoni G. B. 2005 19 196 203 - 27.
Amygdala activation in affective priming: a magnetoencephalogram study. Neuroreport.Garolera M. Coppola R. Muñoz K. E. Elvevåg B. Carver F. W. Weinberger D. R. Goldberg T. E. 2007 Sep 17;18 14 1449 53 - 28.
Geroldi C. Rossi R. Calvagna C. Testa C. Bresciani L. Binetti G. Zanetti O. Frisoni G. B. 2006 Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J Neurol. Neurosurg. Psychiatry77 1219 1222 - 29.
Orthogonal arrangement of rhythm-generating microcircuits in the hippocampus.Gloveli T. Dugladze T. Rotstein H. G. Traub R. D. Monyer H. Heinemann U. MA Whittington Kopell. N. J. 2005 13295 13300 - 30.
Clinical validità of Braak neuropathological staging in the oldest-old. Acta neuropatholGold G. Bouras C. Kovari E. Canito A. Glaria B. G. Malky A. et al. 2000 - 31.
Goldensohn ES. Use of EEG for evaluation of focal intracranial lesions. In: Klass DW, Daly DD, editors. Current practice of clinical electroencephalography. New York: Raven;1979 307 341 - 32.
Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia. BrainGolob E. J. Irimajiri R. Starr A. 2007 130 740 752 - 33.
Hamalainen A. Pihlaimaki M. Tanila H. Hanninen T. Niskanen E. Tervo S. Karjalainen P. A. Vanninen R. L. Soininen H. Increased f. M. R. I. responses during. encoding in. mild cognitive. impairment Neurobiology. of Aging. 2006 doi:10.1016/j.neurobiolaging.2006.08.008 - 34.
Discrimination of Alzheimer’s disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin NeurophysiolHuang C. Wahlund L. O. Dierks T. Julin P. Winblad B. Jelic V. 2000 11 1961 7 - 35.
CP Hughes Berg. L. Danziger W. L. Cohen L. A. Martin R. L. 1982 A new clinical rating scale for the staging of dementia. BrJ Psychiatry140 1225 30 - 36.
Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease. Neurobiol AgingJelic V. Johansson S. E. Almkvist O. Shigeta M. Julin P. Nordberg A. Winblad B. Wahlund L. O. 2000 21 4 533 40 - 37.
Journal of Neurology, Neurosurgery, and PsychiatryJelic V. Julin P. Shigeta M. Nordberg A. Lannfelt L. Winblad B. Wahlund L. O. Apolipoprotein E. ε. allele decreases. functional connectivity. in Alzheimer’s. as disease measured. by E. E. G. coherence 1997 63 59 65 - 38.
Journal of Zhejiang University SCIENCE BJiang Z. Study on. E. E. G. power coherence in. patients with. mild cognitive. impairment during. working memory. task 2005 6 1213 1219 - 39.
Inter and intra-hemispheric EEG coherence in patients with mild cognitive impairment at rest and during working memory task. Journal of Zhejiang University SCIENCE BJiang Z. Zheng L. 2006 5 357 364 - 40.
Cortical responses to sustained and divided attention in Alzheimer’s disease. NeuroimageJohannsen P. Jacobsen J. Bruhn P. Gjedde A. 1999 10 269 281 - 41.
Johnson JD. The conversational brain: fronto-hippocampal interaction and disconnection. Medical Hypotheses2006 67 759 764 - 42.
Brain Res RevKlimesch W. Sauseng P. Hanslmayr S. E. E. G. alpha oscillations. The inhibition. timing hypothesis. 2007 53 63 88 - 43.
Brain Res RevKlimesch W. E. E. G. alpha theta oscillations. reflect cognitive. memory performance. a. review analysis 1999 29 169 95 - 44.
Neurobiol AgingKoenig T. Prichep L. Dierks T. Hubl D. Wahlund L. O. John E. R. Jelic V. Decreased E. E. G. synchronization in. Alzheimer’s disease. mild cognitive. impairment 2005 26 2 165 71 - 45.
Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg PsychiatryKramer J. H. Reed B. R. Mungas D. Weiner M. W. Chui H. C. 2002 72 217 20 - 46.
HippocampusLavenex P. Amaral D. G. Hippocampal-neocortical interaction. a. hierarchy of. associativity 2000 10 420 430 - 47.
Lawton MP, Brodie EM 1969 Assessment of older people: self maintaining and instrumental activity of daily living. J Gerontol.9 179 86 - 48.
Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings. J Neurol Neurosurg PsychiatryLeocani L. Locatelli T. Martinelli V. Rovaris M. Falautano M. Filippi M. Magnani G. Comi G. 2000 69 192 8 - 49.
Focused attention deficits in patients with Alzheimer’s disease and midl cognitive impairment. Brain and cognitionLevinoff E. J. Saumier D. Chertkow H. 2005 57 127 130 - 50.
Proc Natl Acad Sci USALlinas R. R. Ribary U. Jeanmonod D. Kronberg E. Mitra P. P. Thalamocortical dysrhythmia. a. neurological neuropsychiatric syndrome. characterized by. magnetoencephalography 1999 96 26 15222 7 - 51.
Models of neuronal populations: the basic mechanism of rhythmicity. In: Corner MA, Swaab DF, editors. Perspectives of brain research. Progress in brain research,Lopes da. Silva F. H. van Rotterdam A. Barts P. van Heusden E. Burr W. 45 Amsterdam: Elsevier;1976 281 308 - 52.
NeurologyMM Machulda Ward. H. A. Borowski B. Gunter J. L. Cha R. H. O’Brien Pc. et al. Comparison od. memory f. M. R. I. response among. normal M. C. I. Alzheimer’s patients. 2003 61 500 506 - 53.
Gamma oscillations dynamically couple hippocampal CA3 and CA1 regions during memory task performance. PNAS,Montgomery S. M. Buzsaki G. 2007 104 14495 14500 - 54.
Moretti D. V. Fracassi C. Pievani M. Geroldi C. Binetti G. Zanetti O. Sosta K. Rossini P. M. Frisoni G. B. 2009 Increase of theta/gamma ratio is associated with memory impairment. Clin. Neurophysiol. 120(2), 295-303 - 55.
Moretti D. V. Pievani M. Fracassi C. Binetti G. Rosini S. Geroldi C. Zanetti O. Rossini P. M. Frisoni G. B. 2008 Increase of theta/gamma and alpha3/alpha2 ratio is associated with amygdalo-hippocampal complex atrophy. J. Alzheimer Disease, 120 (2), 295-303. - 56.
Individual analysis of EEG frequency and band power in mild Alzheimer’s disease. Clin NeurophysiolMoretti D. V. Babiloni C. Binetti G. Cassetta E. Dal Forno. G. Ferreri F. Ferri R. Lanuzza B. Miniussi C. Nobili F. Rodriguez G. Salinari S. Rossini P. M. 2004 115 299 308 - 57.
Moretti D. V. Miniussi C. Frisoni G. B. Geroldi C. Zanetti O. Binetti G. Rossini P. M. 2007a Hippocampal atrophy and EEG markers in subjects with mild cognitive impairment. Clinical neurophysiology118 2716 2729 - 58.
Moretti D. V. Miniussi C. Frisoni G. B. Zanetti O. Binetti G. Geroldi C. Galluzzi S. Rossini P. M. 2007b Vascular damage and EEG markers in subjects with mild cognitive impairment. Clinical Neurophysiolog.118 1866 1876 - 59.
Theta resynchronization during reconsolidation of remote contextual fear memory. Neuroreport.Narayanan R. T. Seidenbecher T. Sangha S. Stork O. Pape H. C. 2007 Jul 16;18 11 1107 11 - 60.
Advances in early detection of Alzheimer’s disease. Nature MedicineNestor P. J. Scheltens P. Hodges J. R. 2004 10 34 41 - 61.
Nunez P. L. Srinivasan R. A. theoretical basis. for standing. traveling brain. waves Clinical. Neurophysiology 2006 117 11 2425 2435 Szelies B, Mielke R, Kessler J, Heiss WD. EEG power changes are related with regional cerebral glucose metbolism in vascular dementia. Clin Neurophysiol 1999;110:615-20. - 62.
Nunez P. L. Wingeier B. M. Silberstein R. B. 2001 Spatial- temporal structures of human alpha rhythms: theory, microcurrent sources, multiscale measurements, and global binding of local networks. Hum. Brain Mapp.13 125 164 - 63.
Paré D. Collins D. R. Pelletier J. G. 2002 Amygdala oscillations and the consolidation of emotional memories. Trends Cogn Sci. 6(7), 306-314. - 64.
Ann NeurolPariente J. Cole S. Henson R. Clare L. Kennedy A. Rossor m. et al. Alzheimer’s patients. engage an. alternative network. during a. memory task. 2005 59 870 879 - 65.
Petersen R. C. Doody R. Kurz A. Mohs R. C. Morris J. C. Rabins P. V. Ritchie K. Rossor M. Thal L. Winblad B. 2001 Current concepts in mild cognitive impairment. Arch Neurol 58(12), 1985-92. - 66.
Petersen R. C. Smith G. E. Ivnik R. J. Tangalos E. G. Schaid S. N. Thibodeau S. N. Kokmen E. Waring S. C. Kurland L. T. 1995 Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memoryimpaired individuals. J Am Med Assoc273 1274 8 - 67.
Petersen R. C. Smith G. E. Waring S. C. Ivnik R. J. Kokmen E. Tangelos E. G. 1997 Aging, memory, and mild cognitive impairment. Int Psychogeriatr; 9 (Suppl. 1), 65-9. - 68.
Int PsychogeriatrPetersen R. C. Smith G. E. Waring S. C. Ivnik R. J. Kokmen E. Tangelos E. G. Aging memory. mild cognitive. impairment 1997 Suppl. 1):65-9.Petersen RC. Mild cognitive impairment: transition between aging and Alzheimer’s disease.Neurologia. 2000 Mar;15 3 93 101 - 69.
EEG synchronization likelihood in midl cognitive impairment and Alzheimer’s disease during a working memory task. Clin NeurophysiolPijnenburg Y. A. L. Made Y. Knol D. L. van Cappellen van Walsum. A. M. Knol D. L. Scheltens P. Stam C. J. E. E. 2004 115 1332 1339 - 70.
Portet F. Ousset P. J. Visser P. J. Frisoni G. B. Nobili F. Scheltens Ph. Vellas B. Touchon J. the M. C. I. Working Group. of the. European Consortium. on Alzheimer’s. Disease . E. A. D. C. 2006 Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease. J Neurol Neurosurg Psychiatry77 714 718 - 71.
Price JL, Morris JC. Tangles and plaques in nondemented aging and preclinical Alzheimer’s disease. Ann Neurol1999 45 358 368 - 72.
Radloff, LS 1977 The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement1 385 401 - 73.
Rosen W. G. Terry R. D. Fuld P. A. Katzman R. Peck A. 1980 Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7(5), 486-8. - 74.
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement Geriatr Cogn Disord.Rozzini L. Vicini Chilovi. B. Conti M. Delrio I. Borroni B. Trabucchi M. Padovani A. 2008 25 1 32 6 - 75.
Theta coupling in the human electroencephalogram during a working memory task. Neurosci LettSauseng P. Klimesch W. Doppelmayr M. Hanslmayr S. Schabus M. Gruber W. R. 2004 354 123 126 - 76.
Spatial and temporal relationships between plaques and tangles in Alzheimer pathology. Neurobiol AgingSchonheit B. Zarski R. Ohm T. G. 2004 25 697 711 - 77.
Shulman K. I. Clock-drawing is. it the. ideal cognitive. screening test?. Int J. Geriatr Psychiatry. 2000 15 548 561 - 78.
Amygdalar and hippocampal theta rhythm synchronization during fear memory retrieval. ScienceSeidenbecher T. Laxmi T. R. Stork O. Pape H. C. 2003 301 846 850 - 79.
Spinnler H. Tognoni G. 1987 Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 6 (suppl 8),1-120. - 80.
EEG synchronization in mild cognitive impairment and Alzheimer’s disease. Acta Neurol ScandStam C. J. van der Made Y. Pijnenburg Y. A. Scheltens P. E. E. 2003 - 81.
The functional states of the thalamus and the associated neuronal interplay. Physiol RevSteriade M. Llinas R. R. 1988 68 649 742 - 82.
Grouping of brain rhythms in corticothalamic systems. NeuroscienceSteriade M. 2006 137 1087 1106 - 83.
Clin NeurophysiolSzelies B. Mielke R. Kessler J. Heiss W. D. E. E. G. power changes. are related. with regional. cerebral glucose. metbolism in. vascular dementia. 1999 615 20 - 84.
Abnormal visual search in mild cognitive impairment and Alzheimer’s disease. NeurocaseTales A. Haworth J. Nelson S. Snowden R. J. Wilcock G. 2005a 11 80 84 - 85.
Abnormal spatial and non-spatial cueing effects in mild cognitive impairment and Alzheimer’s disease. Neurocase.Tales A. Snowden R. J. Haworth J. Wilcock G. 2005 b Feb;11 1 85 92 - 86.
Biol Psychiatry.Young K. A. Holcomb L. A. Bonkale W. L. Hicks P. B. Yazdani U. German D. C. . H. T. T. L. P. R. polymorphism enlargement of. the pulvinar. unlocking the. backdoor to. the limbic. system 2007 Mar 15;61 6 813 8 - 87.
Zalay OC, Bardakjian BL. Simulated mossy fiber associated feedforward circuit functioning as a highpass filter. Conf Proc IEEE Eng Med Biol Soc.2006 1 4979 82 - 88.
Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia. Ital J Neurol SciZappoli R. Versari A. Paganini M. Arnetoli G. Muscas G. C. Gangemi P. F. Arneodo M. G. Poggiolini D. Zappoli F. Battaglia A. 1995 16 6 341 76 - 89.
Alpha spectral power and coherence in the patients with mild cognitive impairment during a three-level working memory task. Journal of Zhejiang University SCIENCE BZheng L. Jiang Z. Yu E. 2007 8 584 592